Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
Crossref DOI link: https://doi.org/10.1186/s13000-016-0544-9
Published Online: 2016-09-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brcic, Luka
Jakopovic, Marko
Misic, Marija
Seiwerth, Fran
Kern, Izidor
Smojver-Jezek, Silvana
Quehenberger, Franz
Samarzija, Miroslav
Seiwerth, Sven
Funding for this research was provided by:
Roche Croatia
Pfizer Croatia
